在急性心肌梗塞中,人类流行病蛋白4的预后价值
Yi Tang1, Wen-Yu Zhu2, Si-Ling Peng2
1Department of Cardiology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Clinical Medicine Research Center of Heart Failure of Hunan Province, Hunan Normal University, Changsha, 410005, People's Republic of China.
人类外皮膜蛋白4 (HE4) 是一种潜在的新生物标志物,用于预测急性心肌梗塞 (AMI) 患者的结果. 较高的HE4水平表明,在AMI后,心脏主要不良事件的风险增加.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 预测医学是一种预测医学.
背景情况:
- 急性心肌梗塞 (AMI) 仍然是全球主要的死亡原因.
- 准确的预后标记对于风险分层和指导AMI患者的治疗至关重要.
- 人类外皮膜蛋白4 (HE4) 已成为各种临床环境中的潜在生物标志物.
研究的目的:
- 在被诊断患有急性心肌梗塞 (AMI) 的患者中,评估人类外皮膜蛋白4 (HE4) 的预后意义.
主要方法:
- 连续212名AMI患者的队列被纳入.
- 在基线时测量了血HE4水平.
- 患者在出院后被跟踪主要心脏不良事件 (MACE).
主要成果:
- 升高的HE4水平与AMI患者的MACE风险增加独立相关 (HR = 1.004,P = 0.002).
- 患有HE4水平高于532.9 pmol/L的患者表现出明显更高的MACE率 (HR = 4.044,P < 0.001).
- HE4表现出MACE的良好预测性能,其AUC为0.734 (P <0.001).
结论:
- 人类外皮膜蛋白4 (HE4) 是一种新的预后生物标志物,可用于急性心肌梗塞患者.
- HE4可能有助于识别有较高心脏不良事件风险的AMI患者.
- 需要进一步的研究来验证HE4在AMI预后中的作用.
更多相关视频
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...